Cargando…

Pro-oxidant antioxidant balance in patients with non-alcoholic fatty liver disease

AIM: We aimed to determine these parameters in patients with non-alcoholic fatty liver disease using pro-oxidant antioxidant balance assay. BACKGROUND: In human, pro-oxidants and antioxidants are normally produced and there is a balance between production and deletion of them. When the balance betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nobakht Motlagh Ghoochani, Bibi Fatemeh, Ghafourpour, Mohsen, Abdollahi, Fateme, Tavallaie, Shima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536017/ https://www.ncbi.nlm.nih.gov/pubmed/31191836

Ejemplares similares

Barberry Administration and Pro-Oxidant–Antioxidant Balance in Patients With Metabolic Syndrome
por: Mohammadi, Akram, et al.
Publicado: (2014)

The controversial effect of smoking and nicotine in SARS-CoV-2 infection
por: Salehi, Zahra, et al.
Publicado: (2023)

Effect of ghrelin on serum metabolites in Alzheimer’s disease model rats; a metabolomics studies based on 1H-NMR technique
por: Goshadrou, Fatemeh, et al.
Publicado: (2018)

Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease
por: García‐Ruiz, Carmen, et al.
Publicado: (2018)

The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
por: Badali, Taghi, et al.
Publicado: (2023)

The metabolome profiling of obese and non-obese individuals: Metabolically healthy obese and unhealthy non-obese paradox
por: Chashmniam, Saeed, et al.
Publicado: (2020)

Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
por: Monserrat-Mesquida, Margalida, et al.
Publicado: (2020)

Prooxidant-Antioxidant Balance in Patients with Systemic Lupus Erythematosus and Its Relationship with Clinical and Laboratory Findings
por: Jafari, Seyyed Mehdi, et al.
Publicado: (2016)

Serum pro-oxidant/antioxidant balance in term versus preterm neonates
por: Boskabadi, Hassan, et al.
Publicado: (2022)

Determining Pro-Oxidant Antioxidant Balance (PAB) and Total Antioxidant Capacity (TAC) in Patients with Schizophrenia
por: Zahedi Avval, Farnaz, et al.
Publicado: (2018)

The Effect of Silver Nanoparticles on Antioxidant/Pro-Oxidant Balance in a Murine Model
por: Docea, Anca Oana, et al.
Publicado: (2020)

Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
por: Ore, Ayokanmi, et al.
Publicado: (2019)

Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease
por: Kumar, Ramesh, et al.
Publicado: (2012)

Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients?
por: Sohrabi, Masoudreza, et al.
Publicado: (2021)

Peter Eckl: Research on the Pro-/Antioxidant Balance
por: Bresgen, Nikolaus, et al.
Publicado: (2022)

Adherence to oxidative balance scores and lower odds of non-alcoholic fatty liver disease: a case–control study
por: Sohouli, Mohammad Hassan, et al.
Publicado: (2023)

Predicted pro-inflammatory hs-CRP score and non-alcoholic fatty liver disease
por: Okekunle, Akinkunmi Paul, et al.
Publicado: (2023)

Prognostic Factors Associated With Sleep Duration: Serum Pro-Oxidant/Antioxidant Balance and Superoxide Dismutase 1 as Oxidative Stress Markers and Anxiety/Depression
por: Darroudi, Susan, et al.
Publicado: (2023)

Investigation of Thiol/Disulfide Balance in Obese Rats with Non-Alcoholic Fatty Liver Disease
por: Tursun, Serkan, et al.
Publicado: (2021)

COPD: balancing oxidants and antioxidants
por: Fischer, Bernard M, et al.
Publicado: (2015)

Metabolomics diagnostic approach to mustard airway diseases: a preliminary study
por: Ghoochani, BiBi Fatemeh Nobakht Mothlagh, et al.
Publicado: (2018)

Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial
por: Kermani, Tayyebeh, et al.
Publicado: (2015)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat
por: Jiang, Wei, et al.
Publicado: (2016)

Cynanchum atratum Alleviates Non-Alcoholic Fatty Liver by Balancing Lipogenesis and Fatty Acid Oxidation in a High-Fat, High-Fructose Diet Mice Model
por: Wang, Jing-Hua, et al.
Publicado: (2021)

Carboxylated Graphene Oxide as a Nanocarrier for Drug Delivery of Quercetin as an Effective Anticancer Agent
por: Yaghoubi, Fatemeh, et al.
Publicado: (2022)

LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
por: Ceccarelli, Sara, et al.
Publicado: (2015)

The Association Between the Dietary Inflammatory Index (DII) and Some Serum Oxidative Stress Markers in Non-Alcoholic Fatty Liver Disease: Case- Control
por: Moradi, Fateme, et al.
Publicado: (2022)

PRO-OXIDANTS AND ANTIOXIDANTS IN RETINOPATHY OF PREMATURITY
por: Banjac, Lidija, et al.
Publicado: (2018)

Pro-oxidant/antioxidant balance controls pancreatic β-cell differentiation through the ERK1/2 pathway
por: Hoarau, E, et al.
Publicado: (2014)

Comprehensive laboratory reference intervals for routine biochemical markers and pro‐oxidant‐antioxidant balance (PAB) in male adults
por: Ghazizadeh, Hamideh, et al.
Publicado: (2020)

Association between Hypertension and Stroke Recurrence as Modified by Pro-oxidant–Antioxidant Balance: A Multi-Center Study
por: Pham, Thu T. M., et al.
Publicado: (2023)

Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Behrouz, Vahideh, et al.
Publicado: (2017)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
por: Boyle, Marie, et al.
Publicado: (2019)

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
por: Zheng, Yiyuan, et al.
Publicado: (2022)

Serum Alkaline Phosphate Level Associates with Metabolic Syndrome Components Regardless of Non-Alcoholic Fatty Liver; A Population-Based Study in Northern Iran
por: Sohrabi, Masoudreza, et al.
Publicado: (2023)

Investigation of Serum Oxidized Low-Density Lipoprotein IgG Levels in Patients with Angiographically Defined Coronary Artery Disease
por: Moohebati, Mohsen, et al.
Publicado: (2014)

Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease
por: Heredia, Natalia I., et al.
Publicado: (2022)

High-dose testosterone supplementation disturbs liver pro-oxidant/antioxidant balance and function in adolescent male Wistar rats undergoing moderate-intensity endurance training
por: Sadowska-Krępa, Ewa, et al.
Publicado: (2020)

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
por: Karami, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j4hic2c6f40tb0i9vgmqmpno5q